@genaera.com Pages on BioPortfolio:

BioPortfolio - Genaera
Genaera is developing squalamine for the treatment of wet age-related macular .. . Genaera is currently conducting three phase II trials of squalamine in AMD ...
http://www.bioportfolio.com/search/Genaera.html...

BioPortfolio - Genaera - Profile
Genaera Corporation is a biopharmaceutical company committed to developing ... to Genaera Corporation on March 9, 2001. Genaera maintains its headquarters ...
http://www.bioportfolio.com/biocorporate/4330-Genaera.pdf...

BioPortfolio - HPH 12
Genaera March 2001 Magainin Pharmaceuticals | HPH 12 | Genaera Pharma ... Recent Search Terms used to find this page: genaera.com | Genaera March 2001 ...
http://www.bioportfolio.com/search/HPH_12.html...

BioPortfolio - Biocorporate Search
Genaera Corporation is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. ...
http://www.bioportfolio.com/biocorporate/search.php?allticke...

BioPortfolio - bago in the news argentina
Genaera has an exclusive agreement with Laboratorios Bago to develop and commercialize ... Genaera Initiates Pivotal Phase II Clinical Trial of LOMUCIN(
TM . ...
http://www.bioportfolio.com/search/bago_in_the_news_argentin...

BioPortfolio - MEDI-528
Genaera Corporation Discontinues LOMUCIN(TM) in Cystic Fibrosis . ... Genaera also anticipates over the next year that MedImmune, a unit of AstraZeneca, ...
http://www.bioportfolio.com/search/MEDI-528.html...

BioPortfolio - PTP1B clinical trials
Genaera Corporation Presents Data on Mechanism of Inhibition of . ... Genaera Releases Phase 1 Data and New Preclinical Data on the CNS . ...
http://www.bioportfolio.com/search/PTP1B_clinical_trials.htm...

NASDAQ Biotechnology Companies - Eclipsys - Humana
FMSPR · Fresenius Medical Care AG, NYSE, Pharmaceutical Preparations. GENR · GENAERA CORP, Nasdaq, Biotech. GNSC · GENAISSANCE PHARMACEUTICALS, Nasdaq ...
http://www.bioportfolio.com/nasdaq/nasdaq_eclipsys_humana.ht...

Results from other life science and pharmaceutical sites:

Genaera Corporation Phase 2a Data for MEDI-528 Presented at CHEST ...
Genaera Corporation is developing trodusquemine (MSI-1436) for type 2 diabetes and obesity currently in phase 1 clinical testing and has a fully ...
http://www.biospace.com/news_story.aspx?NewsEntityId=115043...

Genaera Releases Phase 1 Data and New Preclinical Data on the CNS ...
Interim results from Genaera's second Phase 1 clinical trial (Study MSI-1436C- 103) of MSI-1436, a novel inhibitor of PTP1B, demonstrated that the drug was ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=...

Genaera Corporation Begins Phase 1b Trial of Trodusquemine (MSI ...
1 Dec 2008 ... MSI-1436 is also being evaluated in preclinical studies using a once-weekly subcutaneously administered formulation which Genaera expects to ...
http://www.biospace.com/news_story.aspx?NewsEntityId=118987...

Genaera Announces Two Respiratory Program Presentations at the ...
The first study demonstrates a relationship between Genaera's proprietary mucoregulator target, the human calcium-activated chloride channel (hCLCA1), ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

Genaera Corporation Elects Paul K. Wotton to Board - News ...
"I believe Paul's areas of expertise will be invaluable to Genaera. The management team and I look forward to working closely with Paul and the rest of
our ...
http://www.biospace.com/news_story.aspx?NewsEntityId=101998...

Genaera Corporation to Present at BIO 2004
Genaera Corporation is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

Genaera Corporation to Present at Biotechnology Industry ...
Genaera Corporation is focused on advancing the science and treatment of metabolic diseases. The Company has significant market opportunities with a ...
http://www.biospace.com/news_story.aspx?NewsEntityId=100217...

Genaera Corporation Announces Third Quarter Financial Results ...
30 Sep 2008 ... 14 /PRNewswire-FirstCall/ -- Genaera Corporation (Nasdaq: GENR - News) today announced its financial results for the three- and nine-month ...
http://biz.yahoo.com/prnews/081114/nyf050.html?.v=101...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.